中國華融(02799.HK)及7間附屬遭財政部各罰款10萬人幣
中國華融(02799.HK)公佈,國家財政部對中國華融和7間附屬公司2014至2019年度會計信息質量開展了檢查。經檢查,發現公司2014至2019年度不同程度存在內部控制和風險控制失效、會計信息嚴重失真等問題,並依法作出行政處罰決定,對公司和7間附屬公司各給予10萬元人民幣罰款,對相關責任人給予相應罰款。
集團指,上述問題涉及公司2014至2019年度財務報告,不會對當前及未來經營活動產生直接影響。對於財政部檢查發現的問題,公司已經進行全面審視評估,並於2020年度財務報告中相應確認信用減值損失和公允價值變動損失。審計師對公司2020年12月31日合併財務狀況發表了無保留意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.